TITLE

Small Molecule Inhibitors of Stat3 Signaling Pathway

AUTHOR(S)
Jinxia Deng; Grande, Fedora; Neamati, Nouri
PUB. DATE
February 2007
SOURCE
Current Cancer Drug Targets;Feb2007, Vol. 7 Issue 1, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Constitutive activation of the Signal Transducers and Activators of Transcription 3 (Stat3) meditated signaling pathway is very important for cell growth and survival. Compelling evidence from mechanistic studies with antisense, RNA interference (RNAi), peptides, and small molecular inhibitors indicate that blocking Stat3 signaling can lead to successful suppression of tumor cell growth and apoptosis. Thus, Stat3 is an attractive molecular target for the development of novel cancer therapeutics. In this article, we present the first comprehensive review focusing on small molecule inhibitors that effectively block the Stat3 signaling pathway. These inhibitors, from a structural point of view, are divided into five classes of compounds. They include (1) natural products and derivatives, such as curcumin, resveratrol and others, (2) tyrphostins, (3) platinum-containing complexes, (4) peptidomimetics, and (5) azaspiranes. Some compounds may have multiple targets including Stat3 protein, therefore these compounds need further optimization and validation. The purpose of this review is to provide a resource for researchers interested in Stat3 targeted small molecules which will be beneficial for database development and template design for future drug development.
ACCESSION #
24175432

 

Related Articles

  • Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy. Richardson, Alan; Kaye, Stanley B. // Current Molecular Pharmacology;Nov2008, Vol. 1 Issue 3, p244 

    Conventional chemotherapy for cancer utilizes cytotoxic agents which elicit their therapeutic effect in part through the induction of apoptosis. In contrast, drugs which have been developed more recently and which are referred to as "targeted therapy" may exhibit less unwanted toxicity but in...

  • Macroautophagy as a Target of Cancer Therapy. Lorin, S�verine; Codogno, Patrice; Djavaheri-Mergny, Mojgan // Current Cancer Therapy Reviews;2007, Vol. 3 Issue 3, p199 

    Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of...

  • A Better Way for a Cancer Cell to Die. Lake, Richard A.; van der Most, Robbert G. // New England Journal of Medicine;6/8/2006, Vol. 354 Issue 23, p2503 

    The article discusses dying cancer cells, which can have a positive, negative, or neutral effect on the immune system. Cell death, known as apoptosis, is discussed in detail, as well the benefits of using doxorubicin over using mitomycin in chemotherapy experiments with lab mice. The study...

  • Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde. Cutts, S. M.; Swift, L. P.; Rephaeli, A.; Nudelman, A.; Phillips, D. R. // Current Medicinal Chemistry - Anti-Cancer Agents;Sep2005, Vol. 5 Issue 5, p431 

    The anthracycline group of compounds are amongst the most effective chemotherapy agents currently in use for cancer treatment. They are generally classified as topoisomerase II inhibitors but also have a variety of other targets in cells. It has been known for some years that the anthracyclines...

  • Induction of Apoptosis and Cytotoxic Activities of Iranian Orthodox Black Tea Extract (BTE) Using in vitro Models. Aghbali, Amirala; Abbasabadi, Faranak Moradi; Delazar, Abbas; Hosseini, Sepideh Vosough; Shahneh, Fatemeh Zare; Baradaran, Behzad; Janani, Maryam // Advanced Pharmaceutical Bulletin;2014, Vol. 4 Issue 3, p255 

    Purpose: Plant-derivate therapeutic agents can perform cancer chemotherapeutic activity through triggering apoptotic cell death. Our aim was to investigate the cytotoxic effects, induction of apoptosis, and the mechanism of cell death of Iranian orthodox black tea extracts (BTEs) and hydro...

  • A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. Mellor, H. R.; Ferguson, D. J. P.; Callaghan, R. // British Journal of Cancer;8/8/2005, Vol. 93 Issue 3, p302 

    The quiescent cell population of tumours poses a barrier to the success of many cancer therapies. Most chemotherapeutic drugs target proliferating cells, but the growth fraction of many tumours is low. Based on the multicellular tumour spheroid model, a system was developed using human colon...

  • Current status of the molecular mechanisms of anticancer drug-induced apoptosis: The contribution of molecular-level analysis to cancer chemotherapy. Kim, Ryungsa; Tanabe, Kazuaki; Uchida, Yoko; Emi, Manabu; Inoue, Hideki; Toge, Tetsuya // Cancer Chemotherapy & Pharmacology;Nov2002, Vol. 50 Issue 5, p343 

    Apoptosis is an important phenomenon in cytotoxicity induced by anticancer drugs. Here, we review the current status of the molecular mechanisms of anticancer drug-induced apoptosis in order to assess the contribution of molecular-level analysis to cancer chemotherapy. It is apparent that the...

  • Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors. He Zhang; Haibo Wang; Jianjun Zhang; Guanxiang Qian; Beibei Niu; Xianqun Fan; Jian Lu; Hoffman, Andrew R.; Ji-Fan Hu; Shengfang Ge // Molecular Therapy;Jan2009, Vol. 17 Issue 1, p57 

    Targeting tumor-specific gene abnormalities has become an attractive approach in developing therapeutics to treat cancer. Overexpression of Bcl2 and mutations of p53 represent two of the most common molecular defects in tumors. In the nucleus, p53 induces cell cycle arrest, while it interacts...

  • Promoting apoptosis as a strategy for cancer drug discovery. Fesik, Stephen W. // Nature Reviews Cancer;Nov2005, Vol. 5 Issue 11, p876 

    Apoptosis is deregulated in many cancers, making it difficult to kill tumours. Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive. Apoptosis targets that are currently being...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics